Moreover, VEE particles expressing the tyrosine-related protein-2 (TRP-2) combined with the antagonist anti-CTL antigen-4 (CTLA-4) monoclonal antibody (mAb) generated complete regression of B16F10 melanoma tumors in 50% of immunized mice [89]. The gene discussed is DCT; the disease is melanoma.